Don Knight
- Date:
- 6 Feb 2002
- Reference:
- WF/M/AV/O/03/42
- Part of:
- Wellcome Foundation Ltd
- Archives and manuscripts
About this work
Description
The folder contains a copy of his transcript, also 1 audio tape.
The interview refers to:
* his work at the company from 1970 as head of regulatory affairs (initially part of the medical division this moved to development and later to R&D); relationship with UK re. regulation; FDA submission process and interaction with scientists in BW on this.
* drugs - AZT; Wellbrutin; Exosurf; Actifed.
* includes copies of a 1994 company paper 'Establishing the Industry's Most Efficient Global Development Process' by Don Knight
Publication/Creation
6 Feb 2002
Physical description
3 items
Terms of use
This item is restricted. You will need to complete a Restricted Access form agreeing to anonymise personal data before you will be allowed to view this item. Please see our Access Policy for more details. Restricted until 1 January 2053.
Languages
Where to find it
Location Status Access Closed stores